Calcified Tissue International

, Volume 83, Issue 5, pp 315–323 | Cite as

Factors Influencing Changes in Bone Mineral Density in Patients with Anorexia Nervosa-Related Osteoporosis: The Effect of Hormone Replacement Therapy

  • Isabelle Legroux-Gerot
  • Jean Vignau
  • Francis Collier
  • Bernard Cortet


The purpose of this longitudinal study was to evaluate factors affecting changes in bone mineral density (BMD) in patients with anorexia nervosa (AN) and osteoporosis and, more particularly, to assess the benefits of hormone replacement therapy (HRT) on BMD in these patients. Our study involved 45 AN patients, 12 of whom had been treated by HRT for 2 years following a diagnosis of osteoporosis by densitometry (WHO criteria). Patients’ mean age was 25.3 ± 6.7 years. Mean duration of illness was 5.7 ± 5.3 years. Serum calcium and phosphate were measured at baseline, as were bone remodeling markers. Osteodensitometry by dual-energy X-ray absorptiometry was performed at inclusion and after 2 years. After 2 years, no significant differences were observed between spine, femoral neck, and total hip BMDs either in the HRT group (P = 0.3, P = 0.59, P = 0.58) or in the nontreatment group (P = 0.17, P = 0.68, P = 0.98). Moreover, there were no significant differences between the two groups when changes in spine, femoral neck, and total hip BMDs at 2 years were compared (P = 0.72, P = 0.95, P = 0.58). In both groups, change in weight at 1 year correlated with change in spine BMD at 2 years (r = 0.35, P = 0.04) and change in total-hip BMD at 2 years (r = 0.35, P = 0.04) but not with change in femoral neck BMD at 2 years. Patients with a body mass index (BMI) ≥ 17 kg/m2 at 2 years showed a significant increase in total-hip BMD when compared with patients with a BMI < 17 kg/m2 (+4.4% ± 6.7 vs. −0.5% ± 6.01, P = 0.03). No significant differences were observed for spine and femoral neck BMD. In patients who had recovered their menstrual cycle, significant increases were observed in spine BMD (+4% ± 6.3 vs. −1.9% ± 5.6, P = 0.008), femoral neck BMD (+3% ± 6.2 vs. −2.4% ± 8, P = 0.05), and total-hip BMD (+3% ± 7.1 vs. −3.7% ± 10, P = 0.04). Prevention of bone loss at 2 years in AN patients treated by HRT was not confirmed in this study. We did confirm that increase in weight at 1 year was the most predictive factor for the improvement of spine and hip BMD at 2 years.


Osteoporosis Anorexia nervosa Hormone replacement therapy 


  1. 1.
    Munoz MT, Argente J (2002) Anorexia nervosa in female adolescents: endocrine and bone mineral density disturbances. Eur J Endocrinol 147:275–286PubMedCrossRefGoogle Scholar
  2. 2.
    Hsu LK (1996) Epidemiology of eating disorders. Psychiatric Clin North Am 19:681–760CrossRefGoogle Scholar
  3. 3.
    Herzog W, Minne H, Deter C, Leiding G, Schellberg D, Wuster C et al (1993) Outcome of bone mineral density in anorexia nervosa patients 11.7 years after first admission. J Bone Miner Res 8:597–605PubMedGoogle Scholar
  4. 4.
    Zipfel S, Beumont PJ, Russel J, Herzog W (2000) Osteoporosis in eating disorders. Eur Eat Disord Rev 8:108–116CrossRefGoogle Scholar
  5. 5.
    Grinspoon S, Thomas E, Pitts S, Gross E, Mickley D, Miller K et al (2000) Prevalence and predictive factors for regional osteoporosis in women with anorexia nervosa. Ann Intern Med 133:790–794PubMedGoogle Scholar
  6. 6.
    Bachrach LK, Katzman DK, Litt IF, Guido D, Marcus R (1991) Recovery from osteopenia in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 72:602–606PubMedGoogle Scholar
  7. 7.
    Soyka LA, Grinspoon S, Levitsky LL, Herzog DB, Klibanski A (1999) The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab 84:4489–4496PubMedCrossRefGoogle Scholar
  8. 8.
    Zipfel S, Seibel MJ, Lowe B, Beumont PJ, Kasperk C, Herzog W (2001) Osteoporosis in eating disorders: a follow-up study of patients with anorexia and bulimia nervosa. J Clin Endocrinol Metab 86:5227–5233PubMedCrossRefGoogle Scholar
  9. 9.
    Brotman AW, Stern TA (1985) Osteoporosis and pathologic fractures in anorexia nervosa. Am J Psychiatry 142:495–496PubMedGoogle Scholar
  10. 10.
    Maugars Y, Clochon P, Grardel B, Hary S, Phelip X, Forestier R et al (1991) Etude du retentissement osseux dans 33 cas d’anorexie mentale dont 8 avec une ostéoporose fracturaire. Rev Rhum Mal Osteoart 58:751–758Google Scholar
  11. 11.
    Herzog W, Deter HC, Fiehn W, Petzold E (1997) Medical findings and predictors of long-term physical outcome in anorexia nervosa: a prospective, 12-year follow-up study. Psychol Med 27:269–279PubMedCrossRefGoogle Scholar
  12. 12.
    Grinspoon S, Miller K, Coyle C, Krempin J, Armstrong C, Pitts S, Herzog D, Klibanski A (1999) Severity of osteopenia in oestrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab 84:2049–2055PubMedCrossRefGoogle Scholar
  13. 13.
    Jacoangeli F, Zoli A, Taranto A, Staar Mezzasalma F, Ficoneri C, Pierangeli S et al (2002) Osteoporosis and anorexia nervosa: relative role of endocrine alterations and malnutrition. Eat Weight Disord 7:190–195PubMedGoogle Scholar
  14. 14.
    Bachrach LK, Guido D, Katzman D, Litt IF, Marcus R (1990) Decreased bone density in adolescent girls with anorexia nervosa. Pediatrics 86:440–447PubMedGoogle Scholar
  15. 15.
    Legroux-Gérot I, Vignau J, D’Herbomez M, Collier F, Marchandise X, Duquesnoy B, Cortet B (2007) Evaluation of bone loss and mechanisms in anorexia nervosa. Calcif Tissue Int 81:174–182PubMedCrossRefGoogle Scholar
  16. 16.
    American Psychiatric Association (1996) DSM-IV-R Manuel diagnostique et statistique des troubles mentaux, 4th edn. Masson, ParisGoogle Scholar
  17. 17.
    Kolta S, Ravaud P, Fechtenbaum J, Dougados M, Roux C (2000) Follow-up of individual patients on two DXA scanners of the same manufacturer. Osteoporos Int 11:709–713PubMedCrossRefGoogle Scholar
  18. 18.
    Seeman E, Szmukler GI, Formica C, Tsalamandris C, Mestrovic R (1992) Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise. J Bone Miner Res 7(12):1467–1474PubMedCrossRefGoogle Scholar
  19. 19.
    Klibanski A, Biller BM, Schoenfeld DA, Herzog DB, Saxe VC (1995) The effects of estrogen administratin on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 80:898–904PubMedCrossRefGoogle Scholar
  20. 20.
    Golden NH, Lanzkowsky L, Schebendach J, Palestro CJ, Jacobson MS, Shenker R (2002) The effect of estrogen–progestin treatment on mineral density in anorexia nervosa. J Pediatr Adolesc Gynecol 15:135–143PubMedCrossRefGoogle Scholar
  21. 21.
    Patel S (1999) Effects of oestrogen therapy on bone density in a patient with severe osteoporosis and anorexia nervosa. Ann Rheum Dis 1:66CrossRefGoogle Scholar
  22. 22.
    Hotta M, Shibasaki T, Sato K, Demura H (1998) The importance of body weight history in the occurrence and recovery of osteoporosis in patients with anorexia nervosa: evaluation by dual X-ray absorptiometry and bone metabolic markers. Eur J Endocrinol 139:276–283PubMedCrossRefGoogle Scholar
  23. 23.
    Ward A, Brown N, Treasure J (1997) Persistent osteopenia after recovery from anorexia nervosa. Int J Eat Disord 22:71–75PubMedCrossRefGoogle Scholar
  24. 24.
    Hartman D, Crisp A, Rooney B, Rackow C, Atkinson R, Platel S (2000) Bone density of women who have recovered from anorexia nervosa. Int J Eat Disord 28:107–112PubMedCrossRefGoogle Scholar
  25. 25.
    Valla A, Groenning I, Syversen U, Hoeiseth A (2000) Anorexia nervosa: slow regain of bone mass. Osteoporos Int 11:141–145PubMedCrossRefGoogle Scholar
  26. 26.
    Bass S, Saxon L, Corral A, Rodda C, Strauss B, Reidpath D, Clarke C (2005) Near normalisation of lumbar spine density in young women with osteopenia recovered from adolescent onset anorexia nervosa: a longitudinal study. J Pediatr Endocrinol Metab 18:897–907PubMedGoogle Scholar
  27. 27.
    Miller KK, Lee EL, Lawson EA, Misra M, Minihan J, Grinspoon SK, Gleysteen S, Mickley D, Herzog D, Klibanski A (2006) Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab 91:2931–2937PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Isabelle Legroux-Gerot
    • 1
  • Jean Vignau
    • 2
  • Francis Collier
    • 3
  • Bernard Cortet
    • 1
  1. 1.Department of RheumatologyCHRU Lille, Hôpital Roger SalengroLille cédexFrance
  2. 2.Department of AddictologyCHRU Lille, Hôpital La CharitéLille cédexFrance
  3. 3.Department of GynecologyCHRU Lille, Hôpital Jeanne de FlandreLille cédexFrance

Personalised recommendations